Document is current
Any future updates will be listed below
-
Authors
Vedadi, Ali
Shakik, Sharara
Brown, M. Catherine
Lok, Benjamin H.
Shepherd, Frances A.
Leighl, Natasha B.
Sacher, Adrian
Bradbury, Penelope A.
Xu, Wei
Liu, Geoffrey https://orcid.org/0000-0003-4214-2819
O’Kane, Grainne M.
- License Information
-
More Information
Article History
Accepted: 17 August 2020
First Online: 26 August 2020
Compliance with ethical standards
:
: Dr. Liu reports Grants and honoraria from AstraZeneca and Takeda; honoraria from Novartis, AbbVie; and advisory boards from Roche, Pfizer, Merck, Bristol Myers Squibb, and Bayer. The remaining authors have stated that they have no conflicts of interest. We have full control of all primary data and agree to allow the journal to review data if requested.
: Ethics approval was obtained from the institutional research-ethics board of the University Health Network/Princess Margaret Cancer Centre. The University Health Network is the umbrella legal hospital network entity that includes multiple hospitals, including Princess Margaret Cancer Centre, the location where the study was carried out and where the affiliated authors are attached. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed written consent was obtained from all participants of the study. All data collected through questionnaires were anonymized and contained no identifying information.
: This study was a retrospective, observational, non-interventional study involving human participants.
